DID JAMES LOGAN OSTRANDER CAUSE YOU INVESTMENT LOSSES?
James Ostrander Of NYLIFE Securities And Eagle Strategies Has A Customer Complaint For Alleged Broker Misconduct
Who is James Ostrander of NYLIFE Securities?
James Ostrander (CRD #2442492) who is currently registered with NYLIFE Securities, Eagle Strategies and located in Irvine, California is a subject of one of our many securities industry sales practice abuse investigations.
James Ostrander Customer Complaint
James Ostrander has been the subject of at least one customer complaint that we know about, which was filed in the last year to recover investment losses. The allegations made in the FINRA reported customer complaint for investment losses were that he was misled regarding the purchase, fees and surrender charges associated with a VA purchased in April 2020. James Ostrander’s customer complaint was settled in favor of the investors.
James Ostrander Red Flags & Your Rights As An Investor
Of course, James Ostrander did not admit to any of the allegations. But regardless of whether an arbitration award was entered, a settlement occurred, or the customer complaint is still pending, the allegations made by customers are red flags which should put all current and former customers of James Ostrander at NYLIFE Securities and Eagle Strategies on alert to review carefully the activity and performance of their accounts and question whether James Ostrander has engaged in any stockbroker misconduct that may have caused them investment losses. The large number of customer complaints at NYLIFE Securities and Eagle Strategies also raises questions about the brokerage firm’s supervisory practices. If these red flags raise questions, call us and we will inform you of your rights as an investor.
File A Claim To Recover Your Investment Losses At NYLIFE Securities Due To James Ostrander
If you have questions about NYLIFE Securities, Eagle Strategies, and/or James Ostrander and the management or performance of your accounts, please contact Attorney Pearce for a free initial consultation via email or Toll Free at 1-800-732-2889.